$0.917
+0.022 (+2.35%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Marker Therapeutics Inc (MRKR) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting MRKR is Strong sell.
Marker Therapeutics Inc (MRKR) 20-Day simple moving average is 0.99, while Marker Therapeutics Inc (MRKR) share price is $—, making it Sell.
Marker Therapeutics Inc (MRKR) 60-Day simple moving average is 1.13, while Marker Therapeutics Inc (MRKR) share price is $—, making it Sell.
Technical Analysis for MRKR
AI Technical MRKRAs of 2026-11-07, the technical board for Marker Therapeutics Inc (MRKR) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $0.92 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 41.208, MACD stands at -0.0441 (Sell), Stochastic %K stands at 15.642 (Buy), Stochastic %D stands at 20.845 and CCI stands at -89.185.
MRKR trades below the 60-day SMA (1.13) and below the 200-day SMA (1.34). Immediate resistance sits at Classic R1 1.06, then R2 1.16. Support sits at Classic S1 0.86, then S2 0.77.
Marker Therapeutics Inc (MRKR) Support & Resistance Level
Marker Therapeutics Inc (MRKR) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 41.208 |
| STOCHk_14_3_3 | 15.642 |
| STOCHd_14_3_3 | 20.845 |
| CCI_20 | -89.185 |
| AO_5_34 | -0.095 |
| MOM_10 | -0.067 |
| MACD_12_26_9 | -0.044 |
Marker Therapeutics Inc (MRKR) Relative Strength Index (RSI_14) is 41.208, creating a Neutral signal.
Marker Therapeutics Inc (MRKR) Stochastic %K is 15.642, creating a Buy signal.
Marker Therapeutics Inc (MRKR) Stochastic %D is 20.845, creating a Neutral signal.
Marker Therapeutics Inc (MRKR) CCI_20 is -89.185, creating a Neutral signal.
Marker Therapeutics Inc (MRKR) Awesome Oscillator (AO) is -0.095, creating a Sell signal.
Marker Therapeutics Inc (MRKR) Momentum (MOM) is -0.067, creating a Sell signal.
Marker Therapeutics Inc (MRKR) Moving Average Convergence Divergence (MACD) is -0.044, creating a Sell signal.
Marker Therapeutics Inc (MRKR) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.936 | Sell |
| MA_10 | 0.953 | Sell |
| MA_20 | 0.992 | Sell |
| MA_60 | 1.132 | Sell |
| MA_200 | 1.342 | Sell |
| MA_250 | 1.359 | Sell |
Marker Therapeutics Inc (MRKR) 5-Day simple moving average is 0.936, while Marker Therapeutics Inc (MRKR) share price is $, making it a Sell.
Marker Therapeutics Inc (MRKR) 10-Day simple moving average is 0.953, while Marker Therapeutics Inc (MRKR) share price is $, making it a Sell.
Marker Therapeutics Inc (MRKR) 20-Day simple moving average is 0.992, while Marker Therapeutics Inc (MRKR) share price is $, making it a Sell.
Marker Therapeutics Inc (MRKR) 60-Day simple moving average is 1.132, while Marker Therapeutics Inc (MRKR) share price is $, making it a Sell.
Marker Therapeutics Inc (MRKR) 200-Day simple moving average is 1.342, while Marker Therapeutics Inc (MRKR) share price is $, making it a Sell.
Marker Therapeutics Inc (MRKR) 250-Day simple moving average is 1.359, while Marker Therapeutics Inc (MRKR) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.